![Anders Larnholt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anders Larnholt
Fondateur chez Mallax Pharmaceuticals AB
Profil
Anders Larnholt is the founder of Mallax Pharmaceuticals AB, which is founded in 2020, where he currently holds the title of Head-Mergers & Acquisitions.
He previously worked at Meda AB as VP-Corporate Development & Investor Relations from 2010 to 2013.
Postes actifs de Anders Larnholt
Sociétés | Poste | Début |
---|---|---|
Mallax Pharmaceuticals AB
![]() Mallax Pharmaceuticals AB Financial ConglomeratesFinance Mallax Pharmaceuticals AB is a Swedish pharmaceutical company that aims to build a portfolio of established pharmaceuticals and over-the-counter products for customers and patients. Mallax Pharmaceuticals has subsidiaries in Norway. The company was founded in 2020 by Anders Larnholt, and the CEO is Heidi Tveit. | Fondateur | 01/01/2020 |
Anciens postes connus de Anders Larnholt
Sociétés | Poste | Fin |
---|---|---|
MEDA AB | Investor Relations Contact | 26/11/2013 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Meda AB
![]() Meda AB Pharmaceuticals: MajorHealth Technology Meda AB engages in the research, development, manufacture, and sale of pharmaceutical and medical products. It offers respiratory, dermatology, pain and inflammation, consumer healthcare, and over-the-counter products. The company was founded by Gert Lennart Perlhagen in 1999 and is headquartered in Solna, Sweden. | Health Technology |
Mallax Pharmaceuticals AB
![]() Mallax Pharmaceuticals AB Financial ConglomeratesFinance Mallax Pharmaceuticals AB is a Swedish pharmaceutical company that aims to build a portfolio of established pharmaceuticals and over-the-counter products for customers and patients. Mallax Pharmaceuticals has subsidiaries in Norway. The company was founded in 2020 by Anders Larnholt, and the CEO is Heidi Tveit. | Finance |